CHYM vs SRAD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 02, 2026
CHYM
SRAD
Investment Advisor Scores
SRAD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CHYM | SRAD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 20.5761 | 30.303 | CHYM |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 26.8% | 18.9% | CHYM |
| Earnings Growth | -33.8% | -39.9% | CHYM |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 49.5/100 | 58.2/100 | SRAD |
| Profit Margin | -0.7% | 1.2% | SRAD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CHYM
NeutralMixed signals - no dominant trend phase, RSI 37
SRAD
MarkdownPrice below a falling SMA50 (slope -6.8%), weak momentum, RSI 41
Fundamentals Snapshot
| Metric | CHYM | SRAD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 29.3 | 30.4 |
| Trailing P/E | 4.9 | 192.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | 0.2% |
| Gross Margin | 0.9% | 0.3% |
| Operating Margin | 0.2% | 0.1% |
| EPS | 5.39 | 0.06 |
| Dividend Yield | — | — |